What is Zevra Therapeutics, Inc.'s total revenue?

Zevra Therapeutics, Inc. (ZVRA) reported total revenue of $36.22M in Q1 2026.

How has Zevra Therapeutics, Inc.'s total revenue changed year-over-year?

Zevra Therapeutics, Inc.'s total revenue increased by 77.5% year-over-year, from $20.4M to $36.22M.

What is the long-term trend for Zevra Therapeutics, Inc.'s total revenue?

Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s total revenue has grown at a 38.8% compound annual growth rate (CAGR), from $28.65M to $106.47M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Zevra Therapeutics, Inc. ZVRA Total Revenue

Total Revenue at other companies

BioMarin PharmaceuticalsBMRN

$766.21M+2.8%

Ultragenyx PharmaceuticalRARE

$136M-2.2%

XER

Xeris Biopharma Holdings, Inc.XERS

$83.13M+38.3%

Eton Pharmaceuticals, Inc.ETON

$24.27M+40.4%

Theravance BiopharmaTBPH

$17.7M+15.0%

Relay Therapeutics, Inc.RLAY

$3M-60.9%

Segments

By product

See full

MIPLYFFA$24.6M+43.9%

OLPRUVA$300K+200%

By segment

See full

Reportable Segment$36.22M+77.5%

Other financials

Income statement

See full

Gross profit$34.3M+80.1%

Operating income$52.1M+1,073%

Net income$37.9M+1,323%

EPS (diluted)$0.60+1,100%

Balance sheet

See full

Cash & equivalents$95.6M+156%

Total debt$1.1M-98.1%

Total equity$205.8M+402%

Total assets$278.6M+61.3%

Cash flow

See full

Operating cash flow$6.1M+175%

CapEx$35.0K-64.6%

Free cash flow$6.1M+173%

Valuation

See full

Market cap$773.23M+56.4%

Enterprise value$678.78M+30.8%

P/E6.2×—

P/S6.3×-5.9×

Profitability

See full

Gross margin86.1%+7.2pp

Operating margin-103.9%-43.0pp

Net margin101.6%+60.1pp

FCF margin-75%-30.5pp

Returns & leverage

See full

Return on equity100.7%+60.3pp

Debt / equity0×-1.5×

Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s total revenue?: Zevra Therapeutics, Inc. (ZVRA) reported total revenue of $36.22M in Q1 2026.
How has Zevra Therapeutics, Inc.'s total revenue changed year-over-year?: Zevra Therapeutics, Inc.'s total revenue increased by 77.5% year-over-year, from $20.4M to $36.22M.
What is the long-term trend for Zevra Therapeutics, Inc.'s total revenue?: Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s total revenue has grown at a 38.8% compound annual growth rate (CAGR), from $28.65M to $106.47M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.